Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that ...

The combination met its primary endpoint of percent weight loss following an 8-week treatment period.

Fiber can support weight loss by increasing satiety hormones, slowing eating rate, and decreasing inflammation. The ...

Center City-based Independence said its $239 million loss in 2024 was due to a sharp increase in medical and pharmacy costs ...

The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...

Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...

The effect of glucagon-like peptide 1 receptor agonists on patients with joint infections was a popular topic at the American ...

Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...

After Hims & Hers (HIMS) announced yesterday that the company is broadening its weight loss offering to include Lilly’s (LLY) branded ...

The newest class of weight loss drugs, GLP-1 agonists (like Victoza, Wegovy, or Ozempic), have seen explosive growth in the ...